Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,978 | 254 | 57.9% |
| Travel and Lodging | $2,890 | 10 | 42.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,042 | 21 | $0 (2023) |
| Cardiovascular Systems Inc. | $1,163 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $946.54 | 71 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $698.47 | 48 | $0 (2024) |
| PFIZER INC. | $601.10 | 36 | $0 (2024) |
| Abbott Laboratories | $284.65 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $280.74 | 16 | $0 (2024) |
| Gilead Sciences, Inc. | $134.02 | 12 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $103.30 | 7 | $0 (2020) |
| Medtronic Vascular, Inc. | $96.09 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $466.54 | 26 | PFIZER INC. ($144.94) |
| 2023 | $473.40 | 26 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($120.99) |
| 2022 | $422.77 | 24 | Novartis Pharmaceuticals Corporation ($130.47) |
| 2021 | $366.60 | 23 | Novartis Pharmaceuticals Corporation ($151.42) |
| 2020 | $286.86 | 19 | Novartis Pharmaceuticals Corporation ($87.09) |
| 2019 | $3,554 | 50 | Boston Scientific Corporation ($1,836) |
| 2018 | $676.10 | 54 | Novartis Pharmaceuticals Corporation ($163.62) |
| 2017 | $622.50 | 42 | Novartis Pharmaceuticals Corporation ($179.63) |
All Payment Transactions
264 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/16/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $19.43 | General |
| Category: Medical Device | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: DEVICES | ||||||
| 10/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Cardiovascular | ||||||
| 08/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | Medtronic, Inc. | AVALUS (Device) | Food and Beverage | In-kind items and services | $44.92 | General |
| Category: Heart Valves | ||||||
| 07/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/24/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Cardiac Rhythm Management | ||||||
| 04/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/16/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/04/2024 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/26/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/30/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,281 | 1,602 | $213,397 | $70,406 |
| 2022 | 22 | 1,148 | 1,616 | $284,348 | $88,457 |
| 2021 | 19 | 1,454 | 1,915 | $309,472 | $102,404 |
| 2020 | 21 | 1,283 | 1,643 | $297,585 | $96,813 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 110 | $15,682 | $9,696 | 61.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 49 | $13,842 | $6,383 | 46.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 49 | 49 | $23,854 | $6,239 | 26.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 122 | 123 | $17,777 | $6,203 | 34.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 97 | $11,737 | $5,869 | 50.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 18 | 18 | $22,140 | $5,701 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 78 | 87 | $15,225 | $5,336 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 94 | 109 | $12,971 | $4,347 | 33.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 463 | 574 | $14,348 | $3,424 | 23.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 18 | 36 | $6,480 | $3,173 | 49.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 22 | 22 | $19,280 | $3,124 | 16.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 38 | 38 | $14,546 | $2,045 | 14.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $3,893 | $1,690 | 43.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 13 | 52 | $3,744 | $1,590 | 42.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 19 | 19 | $3,991 | $879.39 | 22.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 16 | 16 | $1,440 | $839.04 | 58.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $2,054 | $822.51 | 40.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 17 | $1,020 | $708.34 | 69.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 44 | 44 | $2,837 | $648.00 | 22.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 16 | $1,035 | $606.72 | 58.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 44 | 44 | $2,614 | $428.00 | 16.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 26 | $1,678 | $271.31 | 16.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 13 | 13 | $715.00 | $250.77 | 35.1% |
| G0278 | Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta | Facility | 2023 | 13 | 13 | $494.00 | $131.69 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 197 | 332 | $39,508 | $14,799 | 37.5% |
About Dr. Christopher Ike, M.D
Dr. Christopher Ike, M.D is a Internal Medicine healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043346893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Ike, M.D has received a total of $6,869 in payments from pharmaceutical and medical device companies, with $466.54 received in 2024. These payments were reported across 264 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,978).
As a Medicare-enrolled provider, Ike has provided services to 5,166 Medicare beneficiaries, totaling 6,776 services with total Medicare billing of $358,080. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Dothan, AL
- Active Since 02/26/2007
- Last Updated 09/01/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1043346893
Products in Payments
- GENERAL VASCULAR ACCESS (Device) $1,810
- Coronary Orbital Atherectomy System (Device) $1,163
- ENTRESTO (Drug) $908.29
- LifeVest (Device) $698.47
- ELIQUIS (Drug) $658.65
- CHANTIX (Drug) $104.31
- VYNDAQEL (Drug) $103.67
- XARELTO (Drug) $103.30
- CARDIOMEMS (Device) $100.64
- CardioMEMS HF System (Device) $67.14
- GENERAL - ULTRASOUND (Device) $64.40
- WATCHMAN (Device) $57.12
- Repatha (Biological) $46.17
- AVALUS (Device) $44.92
- PRADAXA (Drug) $41.48
- CONFIRM RX (Device) $39.32
- LEQVIO (Drug) $38.25
- BRILINTA (Drug) $35.78
- ICDs (Device) $32.86
- ONYX FRONTIER (Device) $30.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dothan
Justin Hovey, M.d, M.D
Internal Medicine — Payments: $40,901
Dr. Sebastian Heersink, Md, MD
Internal Medicine — Payments: $33,960
Dr. Christopher Miller, M.d, M.D
Internal Medicine — Payments: $16,529
John Wessner, M.d, M.D
Internal Medicine — Payments: $15,180
Dr. James Conner, M.d, M.D
Internal Medicine — Payments: $14,834
Frank Crockett, M.d, M.D
Internal Medicine — Payments: $14,445